42 phenotypes from 5 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
F2tm1b(EUCOMM)Hmgu/F2+ C57BL/6N-F2tm1b(EUCOMM)Hmgu/H	decreased bone mineral content	J:211773
	decreased mean corpuscular volume	J:211773
	tremors	J:211773
F2tm1b(EUCOMM)Hmgu/F2tm1b(EUCOMM)Hmgu C57BL/6N-F2tm1b(EUCOMM)Hmgu/H	preweaning lethality, incomplete penetrance	J:211773
F2tm1Jes/F2tm1Jes involves: 129P2/OlaHsd * C57BL/6J	abnormal vitelline vasculature morphology	J:48274
	embryonic lethality, incomplete penetrance	J:48274
	hemorrhage	J:48274
	intracranial hemorrhage	J:48274
	lethality throughout fetal growth and development, incomplete penetrance	J:48274
	lethality, incomplete penetrance	J:48274
	neonatal lethality, complete penetrance	J:48274
	pallor	J:48274
F2tm1Jld/F2tm1Jld B6.129P2-F2tm1Jld	no abnormal phenotype detected	J:144572
F2tm1Jld/F2tm1Jld Tg(Mx1-cre)1Cgn/0 B6.Cg-F2tm1Jld Tg(Mx1-cre)1Cgn	increased susceptibility to bacterial infection	J:144572
F2tm1Jld/F2tm1Sjd involves: 129P2/OlaHsd * C57BL/6J	abnormal blood coagulation	J:144572
	increased bleeding time	J:144572
F2tm1Jld/F2tm1Sjd Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA	abnormal blood coagulation	J:144572
	abnormal heart morphology	J:144572
	cardiac fibrosis	J:144572
	cerebellum hemorrhage	J:144572
	gastrointestinal hemorrhage	J:144572
	genital hemorrhage	J:144572
	heart hemorrhage	J:144572
	hemorrhage	J:144572
	hemothorax	J:144572
	increased bleeding time	J:144572
	intracranial hemorrhage	J:144572
	petechiae	J:144572
	premature death	J:144572
	skin hemorrhage	J:144572
	spinal hemorrhage	J:144572
F2tm1Sjd/F2+ involves: 129P2/OlaHsd	normal homeostasis/metabolism phenotype	J:174629
F2tm1Sjd/F2tm1Sjd involves: 129P2/OlaHsd * Black Swiss	abnormal blood coagulation	J:48273
	abnormal visceral yolk sac morphology	J:48273
	decreased embryo size	J:48273
	distended pericardium	J:48273
	embryo tissue necrosis	J:48273
	embryonic growth arrest	J:48273
	embryonic lethality during organogenesis, incomplete penetrance	J:48273
	hemopericardium	J:48273
	hemorrhage	J:48273
	neonatal lethality, complete penetrance	J:48273
	pale yolk sac	J:48273
	postnatal lethality, complete penetrance	J:48273
	purpura	J:48273
F2tm2Jld/F2+ B6.129P2-F2tm2Jld	abnormal circulating protein level	J:174629
	decreased platelet aggregation	J:174629
	decreased susceptibility to endotoxin shock	J:174629
	increased bleeding time	J:174629
F2tm2Jld/F2+ involves: 129P2/OlaHsd * C57BL/6 * DBA/2J	decreased susceptibility to induced arthritis	J:174629
F2tm2Jld/F2tm2Jld B6.129P2-F2tm2Jld	hemorrhage	J:174629
	postnatal lethality, complete penetrance	J:174629